# Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)

> **NCT06765564** · NA · RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 3 (estimated)

## Conditions studied

- ALS

## Interventions

- **DRUG:** iPSC-MNP

## Key facts

- **NCT ID:** NCT06765564
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-13
- **Primary completion:** 2025-03-13
- **Final completion:** 2025-05-13
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06765564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06765564, "Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06765564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*